The effects of a copper-intrauterine device on the uterine artery blood flow in regularly menstruating women

Human Reproduction

Volumn 13, Issue 7, 1998, Pages 1841-1845

  Jarvela I ^a   Tekay, A ^a   Jouppila, P ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Intrauterine device; Menstrual pain; Pulsatility index; Transvaginal ultrasound; Uterine artery

Indexed keywords

COPPER;

ADULT; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DYSMENORRHEA; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGING; INTRAUTERINE CONTRACEPTIVE DEVICE; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PAIN; PULSATILE FLOW; SCORING SYSTEM; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY;

EID: 0031822871     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.7.1841     Document Type: Article

References (28)

1. Åkerlund, M., Andersson, K.E. and Ingemarsson, I. (1976) Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea. Br. J. Obstet. Gynaecol., 83, 673-678.
2. Alvarez, F., Brache, V., Fernandez, E. et al. (1988) New insights on the mode of action of intrauterine contraceptive devices in women. Fertil. Steril., 49, 768-773.
3. Anttila, L., Koskinen, P., Irjala, K. et al. (1991) Reference intervals for serum sex steroids and gonadotropins in regularly menstruating women. Acta Obstet. Gynecol. Scand., 70, 475-481.
4. Armitage, P. and Berry, G. (1987) Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford.
5. Csapo, A.I., Pulkkinen, M.O. and Henzl, M.R. (1977) The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients. Prostaglandins, 13, 193-199.
6. Davies, A.J., Anderson, A.B. and Turnbull, A.C. (1981) Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstet. Gynecol., 57, 74-78.
7. Dawood, M.Y. (1993) Nonsteroidal antiinfiammatory drugs and reproduction. Am. J. Obstet. Gynecol., 169, 1255-1265.
8. El-Sahwi, S., Toppozada, M., Kamel, M. et al. (1987) Prostaglandins and cellular reaction in uterine flushings. I. Effect of IUD insertion. Adv. Contracept., 3, 291-302.
9. Faundes, A., Segal, S.J., Adejuwon, C.A. et al. (1980) The menstrual cycle in women using an intrauterine device. Fertil. Steril., 34, 427-430.
10. Green, K. and Hagenfeldt, K. (1975) Prostaglandins in the human endometrium. Gas Chromatographic-mass spectrometric quantitation before and after IUD insertion. Am. J. Obstet. Gynecol., 122, 611-614.
11. Hillier, K. and Kasonde, J.M. (1976) Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device. Lancet, 1, 15-16.
12. Johannisson, E. (1987) Mechanism of action of intrauterine devices: biochemical changes. Contraception, 36, 11-22.
13. Kasonde, J.M. and Bonnar, J. (1976) Plasminogen activators in the endometrium of women using intrauterine contraceptive devices. Br. J. Obstet. Gynaecol., 83, 315-319.
14. Mandelin, E., Koistinen, H., Koistinen, R. et al. (1997) Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism? Hum. Reprod., 12, 2671-2675.
15. Moilanen, E., Moilanen, T., Knowles, R. et al. (1997) Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am. J. Pathol., 150, 881-887.
16. Momtaz, M., Zayed, M., Rashid, K. et al. (1994) Doppler study of the uterine artery in patients using an intrauterine contraceptive device. Ultrasound Obstet. Gynecol., 4, 231-234.
17. Moncada, S. and Higgs, A. (1993) The L-arginine-nitrie oxide pathway. N. Engl. J. Med., 329, 2002-2012.
18. Ortiz, M.E. and Croxatto, H.B. (1987) The mode of action of IUDs. Contraception, 36, 37-53.
19. Pirhonen, J. and Pulkkinen, M. (1995) The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study. Acta Obstet. Gynecol. Scand., 74, 549-553.
20. Roy, S. and Shaw, S.T. (1981) Role of prostaglandins in IUD-associated uterine bleeding-effect of a prostaglandin synthetase inhibitor (ibuprofen). Obstet. Gynecol., 58, 101-106.
21. Salvemini, D., Misko, T.P., Masferrer, J.L. et al. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl Acad. Sci. USA, 90, 7240-7244.
22. Sheppard, B.L. (1987) Endometrial morphological changes in IUD users: a review. Contraception, 36, 1-10.
23. Sladkevicius, P., Valentin, L. and Marsal, K. (1993) Blood flow velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound Obstet. Gynecol., 3, 199-208.
24. Sladkevicius, P., Valentin, L. and Marsal, K. (1994) Blood flow velocity in the uterine and ovarian arteries during menstruation. Ultrasound Obstet. Gynecol., 4, 421-427.
25. Steer, C.V., Campbell, S., Pampiglione, J.S. et al. (1990) Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum. Reprod., 5, 391-395.
26. Telfer, J.F., Lyall, F., Norman, I.E. et al. (1995) Identification of nitric oxide synthase in human uterus. Hum. Reprod., 10, 19-23.
27. Ylikorkala, O., Kauppila, A. and Siljander, M. (1978) Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Lancet, ii, 393-395.
28. Zhao, G., Li, M., Zhu, P. et al. (1997) A preliminary morphometric study on the endometrium from patients treated with indomethacin-releasing copper intrauterine device. Hum. Reprod., 12, 1563-1566.